Showing results (311-320 of 333) with videos related to
Sort By:
Pageof 34
Archives of Disease in Childhood|April 24, 2001
Short stature in Noonan syndrome: response to growth hormone therapyJ M Kirk, P R Betts, G E Butler, et al.Molecular Biology of the Cell|March 29, 2011
The effect of Ku on telomere replication time is mediated by telomere length but is independent of histone tail acetylationHui-Yong Lian, E Douglas Robertson, Shin-ichiro Hiraga, et al.Biochemistry|November 5, 1999
Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxinM W Pennington, M D Lanigan, K Kalman, et al.Preventive Medicine Reports|May 19, 2025
Tobacco policy coverage in California jurisdictions before and after enactment of proposition 56Dennis R Trinidad, Candice D Donaldson, Brian Dang, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 12, 2024
Flavored Tobacco Product Use Among California Adolescents Before and Immediately After a Statewide Flavor BanBenjamin W Chaffee, Candice D Donaldson, Elizabeth T Couch, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1D D Donaldson, M J Whitters, L J Fitz, et al.Tobacco Control|December 26, 2023
"I think we can do without [tobacco]": support for policies to end the tobacco epidemic among California adolescentsBenjamin W Chaffee, Candice D Donaldson, Elizabeth T Couch, et al.The Journal of Experimental Medicine|March 19, 2003
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune responseMonica G Chiaramonte, Margaret Mentink-Kane, Bruce A Jacobson, et al.The Journal of Experimental Medicine|March 19, 2003
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2Nancy Wood, Matthew J Whitters, Bruce A Jacobson, et al.The Journal of Experimental Medicine|December 6, 2003
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrenceMasaki Terabe, So Matsui, Jong-Myun Park, et al.Pageof 34